RP Cure Tracker

Trials / NCT04525261

Natural History of Patients With Inherited Retinal Diseases Due to Mutations in RPE65 Gene

Completed Observational Natural history / observational

Sponsor
University of Campania Luigi Vanvitelli
Treatment
Not listed
Gene
RPE65
Conditions
Leber Congenital Amaurosis 2, Retinitis Pigmentosa 20
Ages
3 Years to no upper limit
Enrollment
60 participants
Started
2020-05-01
Main results expected
2020-07-31
Results posted
Not yet
Record last updated
2023-11-29

What the study is testing

Rationale:

In preparation for treatment with gene therapy, this study is being conducted in order to investigate the natural history of Inherited Retinal Dystrophies (IRDs) due to mutations in RPE65 gene. Such a study will help identify suitable patients for therapeutic intervention.

Methodology:

This is a multicenter retrospective, descriptive chart review study designed to assess retinal structure and function in subjects with IRDs due to mutation in RPE65 gene by visual acuity, visual field measurements, Optical Coherence Tomography (OCT), and a number of other vision-related assessments.

Where it runs

Italy (9)

Open on ClinicalTrials.gov for contacts and eligibility